Inventaire - je vrienden en communities zijn je beste bibliotheek - Inventaire

Nonalcoholic fatty liver disease: diagnosis and relation to metabolic syndrome and approach to treatment

gepubliceerd in: Current diabetes report

publicatiedatum: 2008-02-01

belangrijk thema: diagnose, metabool syndroom, leververvetting, leverziekte, niet-alcoholische steatohepatitis

Cites articles 60

Date

Titel

Auteurs

2007-04-16

Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences

Alain da Silva Morais, Noémi K Van Hul
2007-04-01

The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD

Giulio Marchesini, Felicity T Enders, Alastair D. Burt
2007-04-05

Telmisartan, an angiotensin II type 1 receptor blocker, controls progress of nonalcoholic steatohepatitis in rats

Atsushi Nakajima, Hirokazu Takahashi, Masahiko Inamori, Masato Yoneda, Satoru Saito, Yuichi Nozaki, Hironori Mawatari, Hiroyuki Kirikoshi, Shiro Maeyama, Yasuo Terauchi, Tomoyuki Iwasaki
2007-07-01

Effects of nonalcoholic fatty liver disease on the development of metabolic disorders.
2007-08-08

The rosiglitazone story--lessons from an FDA Advisory Committee meeting
2007-02-01

Nonalcoholic fatty liver disease in severely obese subjects

Jason T Machan
2007-06

Pediatric nonalcoholic fatty liver disease (NAFLD): a "growing" problem?
2007-02-02

Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients.
2007-06-01

Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis
2006-10-01

Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease

Raphael Merriman
2006-08-10

Utility of a new model to diagnose an alcohol basis for steatohepatitis
2006-11-01

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

Amalia Gastaldelli, Ralph A DeFronzo
2006-04-01

Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C.
2006-01

STEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?
2006-07-25

Hepatic histology in obese patients undergoing bariatric surgery

Helena Cortez-Pinto, Pedro Marques-Vidal
2006-10-01

Long-term follow-up of patients with NAFLD and elevated liver enzymes

Stergios Kechagias
2006-02-17

Regulation of nuclear translocation of HDAC3 by IkappaBalpha is required for tumor necrosis factor inhibition of peroxisome proliferator-activated receptor gamma function
2006-04-17

A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease
2006-10-01

Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement.

John B Dixon
2006-05-22

The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis

Savino Bruno, Marcello Persico, Vincenzo La Mura, M Masarone
2006-07

Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
2006-05-01

The evolution of severe steatosis after bariatric surgery is related to insulin resistance

Philippe Mathurin, Antoine Hollebecque, Alexandre Louvet, François Pattou
2005-11-01

The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.
2005-01-01

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies
2005-06-01

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

David E. Kleiner, Michael S. Torbenson, Elizabeth M. Brunt, Nonalcoholic Steatohepatitis Clinical Research Network, Mark Van Natta
2005-08-01

Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice.

Pere Ginès, David A. Brenner
2005-02-01

Liver fibrosis

David A. Brenner
2005-05-01

A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease

Giulio Marchesini, Elisabetta Bugianesi, Mario Rizzetto
2005-11-01

Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease
2005-06-01

Sampling variability of liver biopsy in nonalcoholic fatty liver disease

Thierry Poynard
2004-11-01

Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis
2004-07-01

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

James G Kench

Artike - wd:Q37119289

Welcome to Inventaire

de bibliotheek van je vrienden en communities

you are offline